当前位置:首页 - 行情中心 - 大唐药业(920433) - 财务分析 - 现金流量表

大唐药业

(920433)

  

流通市值:7.94亿  总市值:12.00亿
流通股本:1.69亿   总股本:2.56亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金81,327,361.234,265,486.91156,651,377.57127,536,590.19
  收到其他与经营活动有关的现金636,319.6486,955.316,556,284.685,966,161.5
  经营活动现金流入小计81,963,680.8434,352,442.22163,207,662.25133,502,751.69
  购买商品、接受劳务支付的现金13,121,751.379,109,056.639,645,372.4832,049,948.39
  支付给职工以及为职工支付的现金14,174,275.955,801,925.0933,381,350.4427,308,574.92
  支付的各项税费8,520,082.173,406,906.2116,531,623.7113,184,998.41
  支付其他与经营活动有关的现金32,413,060.8718,070,841.5587,047,883.3766,373,363.38
  经营活动现金流出小计68,229,170.3636,388,729.45176,606,230138,916,885.1
  经营活动产生的现金流量净额13,734,510.48-2,036,287.23-13,398,567.75-5,414,133.41
二、投资活动产生的现金流量:
  收回投资收到的现金20,000,000-158,000,000117,000,000
  取得投资收益收到的现金22,273.99-5,356,129.075,162,964.06
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计20,022,273.99-163,356,129.07122,162,964.06
  购建固定资产、无形资产和其他长期资产支付的现金892,313.96631,241.8723,354,749.4417,786,925.58
  投资支付的现金35,000,000-113,300,00094,300,000
  投资活动现金流出小计35,892,313.96631,241.87136,654,749.44112,086,925.58
  投资活动产生的现金流量净额-15,870,039.97-631,241.8726,701,379.6310,076,038.48
三、筹资活动产生的现金流量:
  取得借款收到的现金44,490,015.5423,450,543.7287,812,653.167,520,870.93
  筹资活动现金流入小计44,490,015.5423,450,543.7287,812,653.167,520,870.93
  偿还债务支付的现金48,219,064.8110,000,00095,720,914.8967,086,378.77
  分配股利、利润或偿付利息支付的现金1,123,412.77551,399.8317,605,441.8616,994,284.31
  筹资活动现金流出小计49,342,477.5810,551,399.83113,326,356.7584,080,663.08
  筹资活动产生的现金流量净额-4,852,462.0412,899,143.89-25,513,703.65-16,559,792.15
四、汇率变动对现金及现金等价物的影响-1,846.13919.49-1,351.87-702.15
五、现金及现金等价物净增加额-6,989,837.6610,232,534.28-12,212,243.64-11,898,589.23
  加:期初现金及现金等价物余额19,479,569.8419,479,569.8431,691,813.4831,691,813.48
  期末现金及现金等价物余额12,489,732.1829,712,104.1219,479,569.8419,793,224.25
补充资料:
  净利润-7,998,320.21--83,188,081.18-
  资产减值准备1,782,917.67-14,627,488.02-
  固定资产和投资性房地产折旧15,865,358.88-32,062,962.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧15,865,358.88-32,062,962.31-
  无形资产摊销339,111.3-615,505.69-
  长期待摊费用摊销523,181.23-1,228,676.77-
  固定资产报废损失--11,127.92-
  公允价值变动损失-56,073.95--275,026.47-
  财务费用1,130,840.78-2,241,219.68-
  投资损失14,310.32--536,002.96-
  递延所得税-1,165,621.93--3,593,314.58-
  其中:递延所得税资产减少-1,157,848.8--3,567,573.7-
    递延所得税负债增加-7,773.13--25,740.88-
  存货的减少2,515,860.38-2,009,475.51-
  经营性应收项目的减少26,072,429.38-33,642,911.83-
  经营性应付项目的增加-25,631,480.4--11,679,410.67-
  现金的期末余额12,489,732.18-19,479,569.84-
  减:现金的期初余额19,479,569.84-31,691,813.48-
  现金及现金等价物的净增加额-6,989,837.66--12,212,243.64-
公告日期2026-08-272026-04-292026-04-292025-10-29
审计意见(境内)标准无保留意见
TOP↑